• PDF / 169,037 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 23 Downloads / 131 Views

DOWNLOAD

REPORT

---

1 S

Mucositis: case report A 3-year-old boy developed mucositis while receiving carboplatin and doxorubicin for hepatoblastoma. The boy, who had hepatoblastoma, started receiving IV carboplatin 75 mg/m2 one hour infusion on day 15 and doxorubicin 30 mg/m2 [route not stated] on days 15 and 16 along with cisplatin. After the first cycle, he developed grade 3 mucositis. After completion of carboplatin dose of cycle 1, mucositis was resolved. The doses of carboplatin and doxorubicin were decreased to 50% and 75% respectively, for second and third cycles, which were well tolerated. Nijstad AL, et al. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis. Cancer Chemotherapy and Pharmacology 803501225 86: 445-449, No. 3, Sep 2020. Available from: URL: http://doi.org/10.1007/s00280-020-04130-z

0114-9954/20/1822-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 19 Sep 2020 No. 1822